Skip to main content
. 2016 Oct 4;9(6):302–310. doi: 10.1111/cts.12420

Figure 1.

Figure 1

MYO‐029 serum exposures (observed vs. population fit). (a) Mouse pharmacokinetic (PK) at 1, 5, 20, and 100 mg/kg i.v.; (b) rat PK at 2, 10, and 50 mg/kg i.v.; (c) monkey PK at 10, 30, and 100 mg/kg i.v.; and (d) healthy human PK at 0.3, 1, 3, 7.5, and 11.25 mg/kg i.v.